神经影像学
神经心理学
认知
阿尔茨海默病神经影像学倡议
内科学
医学
生物标志物
心理学
认知功能衰退
阿尔茨海默病
多元统计
多元分析
神经科学
神经功能成像
磁共振成像
睡眠剥夺对认知功能的影响
疾病
肿瘤科
大脑定位
大脑大小
比例危险模型
神经心理评估
脂质过氧化
临床心理学
聚类分析
神经病理学
层次聚类
作者
Aleix Martí Navia,Alejandro López-Bellido,Ángel Balaguer,Sara Ballesta-Martínez,Lourdes Álvarez‐Sánchez,Mar Peretó,Lorena García,Luis Raga,Miguel Baquero,Consuelo Cháfer‐Pericás
标识
DOI:10.1038/s41598-026-60061-4
摘要
Alzheimer’s disease (AD) presents significant clinical heterogeneity in cognitive decline. Neuroimaging profiles and peripheral biomarkers, such as plasma oxidative stress biomarkers could provide information on AD progression. This study evaluates the contribution of baseline neuroimaging features and plasma lipid peroxidation biomarkers to modelling cognitive decline trajectories in early AD. Data were collected from patients with early AD (n = 195), and they were neuropsychologically evaluated to assess their progression. Baseline data included demographics, neuropsychological evaluations, neuroimaging measures and plasma lipid peroxidation levels. Follow-up neuropsychological evaluations were conducted biennially. Individual cognitive decline trajectories were estimated using MMSE and CDR Sum of Boxes (CDR-SB) scores. Multivariate modelling and hierarchical clustering analyses were applied to identify prognostic signatures and patient subgroups. Baseline neuroimaging variables showed significant associations with longitudinal cognitive trajectories, as reflected in MMSE and CDR Sum of Boxes slopes, whereas plasma lipid peroxidation biomarkers did not. Multivariate models based on neuroimaging features demonstrated substantial predictive contribution (conditional R 2 0.825 for MMSE and 0.808 for CDR Sum of Boxes). Hierarchical clustering identified four distinct groups, primarily driven by left Koedam scores, enlarged perivascular spaces, and Fazekas scores. These clusters were significantly associated with differential rates of cognitive decline, particularly for MMSE. In conclusion, structural neuroimaging measures at baseline are robust indicators of cognitive decline in early AD, supporting its utility for individualized prognosis in early AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI